HSCS Graph | HeartSciences Inc.

HSCS Revenue Flow

Filed revenue amounts for 2026-05-01 to 2026-07-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

2026-07-31: Revenue $2.10K; Cost of revenue $760.00; Research and development $906.63K; Selling, general and administrative $2.03M.
2026-04-30: Revenue $0.00*; Cost of revenue $0.00*; Research and development $476.20K*; Selling, general and administrative $2.06M*.
2026-01-31: Revenue $0.00; Cost of revenue $0.00; Research and development $638.58K; Selling, general and administrative $1.29M.
2025-10-31: Revenue $2.42K; Cost of revenue $1.01K; Research and development $727.03K; Selling, general and administrative $1.35M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Net income
2026-07-31	$2.10K	$760.00	$906.63K	$2.03M	$2.94M	-$3.17M
2026-04-30	$0.00*	$0.00*	$476.20K*	$2.06M*	$2.54M*	-$2.75M*
2026-01-31	$0.00	$0.00	$638.58K	$1.29M	$1.93M	-$1.99M
2025-10-31	$2.42K	$1.01K	$727.03K	$1.35M	$2.07M	-$2.35M
2025-07-31	$1.90K	$760.00	$997.21K	$878.05K	$1.88M	-$2.05M
2025-01-31	$0.00	$0.00	$1.03M	$1.34M	$2.37M	-$2.54M
2024-10-31	(m)	(m)	$1.20M	$786.07K	$1.99M	-$2.08M
2024-07-31	(m)	(m)	$1.22M	$850.74K	$2.08M	-$2.05M
2024-01-31	$14.70K	$4.56K	$509.51K	$1.03M	$1.54M	-$1.64M
2023-10-31	$3.90K	$1.52K	$757.30K	$815.02K	$1.57M	-$1.75M
2023-07-31	(m)	(m)	$565.63K	$765.02K	$1.33M	-$1.37M
2023-01-31	$1.95K	$760.00	$643.26K	$667.24K	$1.31M	-$1.34M
2022-10-31	(m)	(m)	$848.98K	$925.93K	$1.77M	-$1.81M
2022-07-31	$3.20K	$2.04K	$434.20K	$997.06K	$1.43M	-$1.57M
2022-01-31	$2.74K	$854.00	$699.01K	$403.16K	$1.10M	-$1.24M
2021-10-31	(m)	(m)	$545.77K	$411.08K	$956.86K	-$1.03M
2021-07-31	$7.48K	$5.76K	$401.11K	$275.06K	$676.17K	-$501.85K

Revenue and expense 6 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Net income
2025-10-31	$4.32K	$1.77K	$1.72M	$2.23M	$3.95M	-$4.41M
2024-10-31	(m)	(m)	$2.42M	$1.64M	$4.06M	-$4.13M
2023-10-31	$3.90K	$1.52K	$1.32M	$1.58M	$2.90M	-$3.12M
2022-10-31	$3.20K	$2.04K	$1.28M	$1.92M	$3.21M	-$3.38M
2021-10-31	$7.48K	$5.76K	$946.89K	$686.14K	$1.63M	-$1.54M

Revenue and expense 9 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Net income
2026-01-31	$4.32K	$1.77K	$2.36M	$3.52M	$5.88M	-$6.39M
2025-01-31	$0.00	$0.00	$3.46M	$2.98M	$6.43M	-$6.67M
2024-01-31	$18.60K	$6.08K	$1.83M	$2.61M	$4.44M	-$4.76M
2023-01-31	$5.15K	$2.80K	$1.93M	$2.59M	$4.52M	-$4.72M
2022-01-31	$10.22K	$6.61K	$1.65M	$1.09M	$2.74M	-$2.78M

Revenue and expense 12 month

Period end	Revenue	Cost of revenue	Research and development	Selling, general and administrative	Operating expenses	Income tax	Net income
2026-04-30	$4.32K	$1.77K	$2.84M	$5.58M	$8.42M	$0.00	-$9.14M
2025-04-30	$4.35K	$1.88K	$4.39M	$3.97M	$8.36M	$0.00	-$8.77M
2024-04-30	$18.60K	$6.08K	$2.88M	$3.44M	$6.32M	(m)	-$6.61M
2023-04-30	$5.15K	$2.80K	$2.46M	$3.65M	$6.12M	(m)	-$6.35M
2022-04-30	$14.37K	$7.89K	$3.00M	$1.71M	$4.72M	(m)	-$4.83M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
DarkHorse Technologies Inc. (ANY)		$0.025B
Binah Capital Group, Inc. (BCG)	United States	$0.020B	6.21
Pineapple Financial Inc. (PAPL)	Canada	$0.026B
AIxCrypto Holdings, Inc. (AIXC)	United States	$0.029B	-1.02
AtlasClear Holdings, Inc. (ATCH)	United States	$0.030B
MDB Capital Holdings, LLC (MDBH)	United States	$0.016B
Fold Holdings, Inc. (FLD)	United States	$0.030B
VerifyMe, Inc. (VRME)	United States	$0.015B	-1.55
House of Doge Inc. (HODO)	United States	$0.015B
TAO Synergies Inc. (TAOX)	United States	$0.033B